Healthcare
Live Price
Offline$184.71
+0.49% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BeiGene, Ltd. (BGNE) is a Healthcare stock with a market cap of $20.21B. The stock last traded around $184.71. Baseline metrics include revenue growth of +40.2%, EPS growth of +659.6%, a dividend yield of 0.0%. What stands out right now is revenue +40.2%, EPS +659.6%, free cash flow +240.6% with operating margin 8.4% and ROIC 4.8%. Valuation already assumes a fairly strong business story at P/E 171.9 and price/sales 6.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BGNE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BGNE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BGNE Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BGNE and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.